Cargando…

A post-incorporation study on the use of palivizumab in the Brazilian public health system

Respiratory syncytial virus (RSV) is the main cause of lower respiratory disease in infants and children under five years of age. As there is no specific treatment for RSV infections, prophylaxis with the specific monoclonal antibody palivizumab (PVZ) has been widely recommended for high-risk cases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batista, Joanna d’Arc Lyra, Ferreira, Maria Angélica Pires, Xavier, Cilene da Silva, de Souza, Ires Tarsila Alves, Cruz, Luciane Nascimento, Polanczyk, Carisi Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto de Medicina Tropical 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845933/ https://www.ncbi.nlm.nih.gov/pubmed/33533808 http://dx.doi.org/10.1590/S1678-9946202163005

Ejemplares similares

Telemedicine-supported transition of stable coronary artery disease patients from tertiary to primary health care facilities: protocol for a randomized non-inferiority trial
por: Batista, Joanna d’Arc Lyra, et al.
Publicado: (2016)

Costs of genetic testing: Supporting Brazilian Public Policies for the incorporating of molecular diagnostic technologies
por: Schlatter, Rosane Paixão, et al.
Publicado: (2015)

The Economic Impact of COVID-19 Treatment at a Hospital-level: Investment and Financial Registers of Brazilian Hospitals
por: Beck da Silva Etges, Ana Paula, et al.
Publicado: (2021)

Effectiveness evaluation of mood disorder treatment algorithms in Brazilian public healthcare patients
por: Lima, Ana F., et al.
Publicado: (2017)

The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV
por: Correa, Analú, et al.
Publicado: (2020)

Hospitalização por Infarto Agudo do Miocárdio: Um Registro de Base Populacional
por: Alves, Leonardo, et al.
Publicado: (2020)

The Profile of the Brazilian Cardiologist - A Sample of Members of the Brazilian Society of Cardiology
por: Faganello, Lucas Simonetto, et al.
Publicado: (2019)

Smoking increases the risk of relapse after successful tuberculosis treatment
por: d’Arc Lyra Batista, Joanna, et al.
Publicado: (2008)

Cost-Effectiveness of High, Moderate and Low-Dose Statins in the Prevention of Vascular Events in the Brazilian Public Health System
por: Ribeiro, Rodrigo Antonini, et al.
Publicado: (2015)

Is Age-targeted full-field digital mammography screening cost-effective in emerging countries? A micro simulation model
por: Souza, Fabiano Hahn, et al.
Publicado: (2013)

Epidemiologia das Doenças Cardiovasculares no Brasil: A Verdade Escondida nos Números
por: Polanczyk, Carisi Anne
Publicado: (2020)

Mortalidade Hospitalar Por Infarto do Miocárdio na América Latina e no Caribe: Revisão Sistemática e Metanálise
por: Alves, Leonardo, et al.
Publicado: (2022)

Dados de Vida Real sobre o Uso da Hidroxicloroquina ou da Cloroquina Combinadas ou Não à Azitromicina em Pacientes com Covid-19: Uma Análise Retrospectiva no Brasil
por: Souza-Silva, Maíra Viana Rego, et al.
Publicado: (2023)

A content validity study of signs, symptoms and diseases/health problems expressed in LIBRAS
por: Aragão, Jamilly da Silva, et al.
Publicado: (2015)

Guadalajara y su región : influencias y dificultades de una metrópoli mexicana
por: Riviére d'Arc, Héléne
Publicado: (1973)

Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil
por: Maia, Carlos R., et al.
Publicado: (2015)

Development of a palivizumab specialty pharmacy management program
por: Harlan, Lana, et al.
Publicado: (2019)

Is immunization with palivizumab really effective in high-risk children?
por: Raguž, Marjana Jerković, et al.
Publicado: (2023)

Studies Recommending Palivizumab Restriction Have Serious Deficiencies
por: Stewart, Dan L.
Publicado: (2010)

Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value
por: Olchanski, Natalia, et al.
Publicado: (2018)

Use of the Coding Causes of Death in HIV in the classification of deaths in Northeastern Brazil
por: Alves, Diana Neves, et al.
Publicado: (2017)

Comparative Assessment of the Effect of Synthetic and Natural Fungicides on Soil Respiration
por: Stefani, Angelo, et al.
Publicado: (2012)

Cost effectiveness of palivizumab in Spain: an analysis using observational data
por: Nuijten, Mark J., et al.
Publicado: (2009)

Neonatal outcomes following new reimbursement limitations on palivizumab in Italy
por: Belleudi, Valeria, et al.
Publicado: (2018)

Pulmonary Deposition of Radionucleotide-Labeled Palivizumab: Proof-of-Concept Study
por: Rajapaksa, Anushi E., et al.
Publicado: (2020)

Reappraisal of the Subtropical Guidelines on Palivizumab Prophylaxis in Congenital Heart Disease
por: Chiu, Shuenn-Nan, et al.
Publicado: (2022)

Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
por: Taylor, Richard S.
Publicado: (2021)

A Systematic Review of Compliance with Palivizumab Administration for RSV Immunoprophylaxis
por: Frogel, Michael
Publicado: (2010)

Fibrin sealant in inguinal hernioplasty: an observational multicentre study in 1,201 patients
por: Descottes, B., et al.
Publicado: (2009)

Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry
por: Marcolino, Milena S., et al.
Publicado: (2021)

Effectiveness of screening for tuberculosis in HIV: a pragmatic clinical trial
por: Santos, Marcela Lopes, et al.
Publicado: (2021)

Utility and quality-adjusted life-years in coronary artery disease: Five-year follow-up of the MASS II trial
por: Brandão, Sara Michelly Gonçalves, et al.
Publicado: (2017)

Incorporation of Brazilian Diatomite in the Synthesis of An MFI Zeolite
por: Vinaches, Paloma, et al.
Publicado: (2019)

Cardiovascular Epidemiology: The Legacy of Sound National and International Studies
por: Fuchs, Sandra C., et al.
Publicado: (2013)

Respiratory infections in children up to two years of age on prophylaxis with palivizumab
por: Monteiro, Ana Isabel M. P., et al.
Publicado: (2014)

Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)
por: Bollani, Lina, et al.
Publicado: (2015)

Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children
por: al-Alaiyan, Saleh, et al.
Publicado: (2015)

Reducing Palivizumab Dose Requirements Through Rational Dose Regimen Design
por: Reuter, Stephanie E., et al.
Publicado: (2018)

Social behavioural adaptation in Autism
por: Forgeot d'Arc, Baudouin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_594amn0p8l3qg65op91cpuk484